➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Merck
Johnson and Johnson
Medtronic
Baxter

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

SUCCINYLCHOLINE CHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Succinylcholine Chloride, and when can generic versions of Succinylcholine Chloride launch?

Succinylcholine Chloride is a drug marketed by Accord Hlthcare, Amneal, Amphastar Pharms Inc, Amring Pharms, Aspiro, Breckenridge, Deva Holding As, Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Indoco, Intl Medication, Micro Labs, Nexus Pharms, Nivagen Pharms Inc, Organon Usa Inc, Sagent Pharms Inc, Somerset Theraps Llc, and Zydus Pharms. and is included in twenty NDAs.

The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.

Drug patent expirations by year for SUCCINYLCHOLINE CHLORIDE
Drug Prices for SUCCINYLCHOLINE CHLORIDE

See drug prices for SUCCINYLCHOLINE CHLORIDE

Recent Clinical Trials for SUCCINYLCHOLINE CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rutgers, The State University of New JerseyN/A
Avera PharmaceuticalsPhase 1/Phase 2

See all SUCCINYLCHOLINE CHLORIDE clinical trials

Pharmacology for SUCCINYLCHOLINE CHLORIDE
Medical Subject Heading (MeSH) Categories for SUCCINYLCHOLINE CHLORIDE

US Patents and Regulatory Information for SUCCINYLCHOLINE CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare SUCCINYLCHOLINE CHLORIDE succinylcholine chloride INJECTABLE;INJECTION 213705-001 May 20, 2020 AP RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Sagent Pharms Inc SUCCINYLCHOLINE CHLORIDE succinylcholine chloride INJECTABLE;INJECTION 215022-001 Mar 29, 2021 AP RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Deva Holding As SUCCINYLCHOLINE CHLORIDE succinylcholine chloride INJECTABLE;INJECTION 214491-001 Dec 21, 2020 AP RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Amring Pharms SUCCINYLCHOLINE CHLORIDE succinylcholine chloride INJECTABLE;INJECTION 210231-001 Jun 4, 2018 AP RX No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Merck
Medtronic
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.